Your browser doesn't support javascript.
loading
Recurrent SARS-CoV-2 mutations in immunodeficient patients.
Wilkinson, S A J; Richter, Alex; Casey, Anna; Osman, Husam; Mirza, Jeremy D; Stockton, Joanne; Quick, Josh; Ratcliffe, Liz; Sparks, Natalie; Cumley, Nicola; Poplawski, Radoslaw; Nicholls, Samuel N; Kele, Beatrix; Harris, Kathryn; Peacock, Thomas P; Loman, Nicholas J.
Afiliação
  • Wilkinson SAJ; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Richter A; Institute of Immunology and Immunotherapy (III), College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Casey A; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Osman H; Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham B15 2TH, UK.
  • Mirza JD; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Stockton J; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Quick J; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Ratcliffe L; Queen Elizabeth Hospital, University Hospitals Birmingham, Birmingham B15 2TH, UK.
  • Sparks N; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Cumley N; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Poplawski R; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Nicholls SN; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Kele B; Virology Department, Royal London Hospital, Barts Health NHS Trust, London, EC1A 7BE, UK.
  • Harris K; Virology Department, Royal London Hospital, Barts Health NHS Trust, London, EC1A 7BE, UK.
  • Peacock TP; Department of Infectious Disease, Imperial College London, London, Westminster W2 1PG, UK.
  • Loman NJ; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham B15 2TT, UK.
Virus Evol ; 8(2): veac050, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35996593
ABSTRACT
Long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in immunodeficient patients are an important source of variation for the virus but are understudied. Many case studies have been published which describe one or a small number of long-term infected individuals but no study has combined these sequences into a cohesive dataset. This work aims to rectify this and study the genomics of this patient group through a combination of literature searches as well as identifying new case series directly from the COVID-19 Genomics UK (COG-UK) dataset. The spike gene receptor-binding domain and N-terminal domain (NTD) were identified as mutation hotspots. Numerous mutations associated with variants of concern were observed to emerge recurrently. Additionally a mutation in the envelope gene, T30I was determined to be the second most frequent recurrently occurring mutation arising in persistent infections. A high proportion of recurrent mutations in immunodeficient individuals are associated with ACE2 affinity, immune escape, or viral packaging optimisation. There is an apparent selective pressure for mutations that aid cell-cell transmission within the host or persistence which are often different from mutations that aid inter-host transmission, although the fact that multiple recurrent de novo mutations are considered defining for variants of concern strongly indicates that this potential source of novel variants should not be discounted.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article